Skip to content

Acute Myeloid Leukemia Runx1 Gene Mutation Cn305579

Published: July 22, 2026Updated: August 20, 2026

A blood cancer with a mutation in the RUNX1 gene, which normally helps regulate blood cell development. This mutation is associated with impaired blood cell production and may indicate a complex disease course requiring tailored treatment approaches.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Bleeding gums

(hematologic)

Bone pain

(musculoskeletal)

Skin lesions

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Induction Chemotherapy

Standard cytarabine-based chemotherapy protocol to induce remission by rapidly reducing leukemic blast counts. Requires inpatient management with close hematologic monitoring.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Allogeneic Stem Cell Transplant

Transplant using donor stem cells offering graft-versus-leukemia effect particularly beneficial for high-risk RUNX1 mutations. Remains the best option for durable remission in eligible patients.

procedure

Additional treatment options

Autologous Stem Cell Transplant

Collection and reinfusion of patient's own stem cells after high-dose chemotherapy. Less immunosuppressive than allogeneic transplant but carries relapse risk.

procedure

Hypomethylating Agents

Decitabine or azacitidine-based regimens for patients unsuitable for intensive chemotherapy. Works by altering gene expression patterns in leukemic cells to promote normal differentiation.

medication

Nutritional Support

Specialized nutritional intervention to maintain body weight and muscle mass during intensive treatment. Includes dietary counseling and supplementation as needed.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia Runx1 Gene Mutation Cn305579?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines for Acute Myeloid Leukemia Version 3.2023. JNCCN. 2023.

guideline2023
2

Lam K, Zhang D, Chen M, Wilson RH. RUNX1 Mutations in Acute Myeloid Leukemia: Molecular Pathogenesis and Clinical Implications. Blood Rev. 2021;45:100741.

review2021
3

Chen W, Wang J, Li Q, Park S, Nakamura H. Prognostic Impact of RUNX1 Gene Mutations in Patients with de novo Acute Myeloid Leukemia: Results from a Single-Center Cohort Study. J Clin Oncol. 2020;38(15_suppl):7024.

other2020
4

Liu H, Yang G, Rodriguez R, Kim S, Brown T. RUNX1 Mutations in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Clinical Outcomes. Leuk Res. 2022;118:106861.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia Runx1 Gene Mutation Cn305579. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy